Screener
Arbutus Biopharma Corporation ABUS Price / book
Price / book at other companies
Other financials
Where this comes from
Calculated from Arbutus Biopharma Corporation’s reported figures.
Based on the most recent quarter.
The source filing: Arbutus Biopharma Corporation’s 10-Q, filed May 13, 2026. Open the filing →
- Filed
- May 13, 2026, 7:31 AM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001447028-26-000021
FAQ
- What is Arbutus Biopharma Corporation's price / book?
- Arbutus Biopharma Corporation (ABUS) reported price / book of 3.4× in Q1 2026.
- How has Arbutus Biopharma Corporation's price / book changed year-over-year?
- Arbutus Biopharma Corporation's price / book decreased by 60.0% year-over-year, from 8.4× to 3.4×.
- What is the long-term trend for Arbutus Biopharma Corporation's price / book?
- Over 5 years (2020 to 2025), Arbutus Biopharma Corporation's price / book has grown at a 20.7% compound annual growth rate (CAGR), from 4.7× to 12.1×.
- What does price / book mean?
- Market capitalization at the quarter end divided by shareholders' equity. The premium (or discount) the market assigns to the company's book equity.
Ask your AI about Arbutus Biopharma Corporation's price / book.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude